# THEOPHYLLINE
> **ANDA214950** · Abbreviated New Drug Application (Generic) · Sponsor: VELZEN PHARMA PVT · Approved 2023-01-30
## Drug
- **FDA Application Number:** ANDA214950
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** THEOPHYLLINE
- **Generic name:** THEOPHYLLINE
- **Active ingredients:** THEOPHYLLINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** VELZEN PHARMA PVT
- **Manufacturer:** Leading Pharma, LLC
- **First approval:** 2023-01-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214950)
---
*AI Analytics · CC0 1.0*